drugset / Trial / NCT02605187

Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management

NCT02605187

Completed 160 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.

Timeline

Start
2015-11
Primary completion
2017-05-22
Completion
2017-05-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 600 mg Oral
Subject Morphine Other / unclassified 50 ug Intrathecal
Subject Morphine Other / unclassified 150 ug Intrathecal
Subject Morphine Other / unclassified 300 ug Intrathecal
Background Acetaminophen Small molecule 650 mg Oral
Background Ibuprofen Small molecule 600 mg Oral

Indications

No indication recorded.